laninamivir has been researched along with naratriptan* in 1 studies
1 other study(ies) available for laninamivir and naratriptan
Article | Year |
---|---|
Quantitative structure-activity relationships, molecular docking and molecular dynamics simulations reveal drug repurposing candidates as potent SARS-CoV-2 main protease inhibitors.
The current outbreak of COVID-19 is leading an unprecedented scientific effort focusing on targeting SARS-CoV-2 proteins critical for its viral replication. Herein, we performed high-throughput virtual screening of more than eleven thousand FDA-approved drugs using backpropagation-based artificial neural networks ( Topics: Acarbose; Angiotensin Amide; Antiviral Agents; Dihydrostreptomycin Sulfate; Drug Repositioning; Enviomycin; Fenoterol; Molecular Docking Simulation; Molecular Dynamics Simulation; Protease Inhibitors; Quantitative Structure-Activity Relationship; SARS-CoV-2 | 2022 |